comparemela.com

Latest Breaking News On - Institutional investors weigh in on madrigal pharmaceuticals - Page 1 : comparemela.com

Bank of America Begins Coverage on Madrigal Pharmaceuticals (NASDAQ:MDGL)

Analysts at Bank of America started coverage on shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) in a research report issued to clients and investors on Monday, Marketbeat Ratings reports. The firm set an “underperform” rating and a $150.00 price target on the biopharmaceutical company’s stock. Bank of America‘s target price would suggest a […]

Madrigal Pharmaceuticals (NASDAQ:MDGL) Trading Down 3 3%

Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) fell 3.3% during mid-day trading on Wednesday . The company traded as low as $225.22 and last traded at $225.22. 43,731 shares were traded during trading, a decline of 92% from the average session volume of 525,723 shares. The stock had previously closed at $232.98. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.